PEPperPRINT
PEPperPRINT produces customized ultra-high density peptide microarrays and uses individualized peptide libraries for drug development, antibody characterization, and protein biomarker discovery.
Press releases
Blog
Why we need to see more investment diversity in the life sciences sector to overcome crises such as the current one
Dr. Bernd Goergen has been working at High-Tech Gründerfonds for the last 12 years. The HTGF Partner is an expert in the field of life sciences. His investment portfolio includes PEPperPRINT, a Heidelberg-based start-up which is making a valuable contribution to the fight against the coronavirus. In this interview, he sheds light on start-ups in the life sciences sector, pharmaceutical innovations and the importance of long-term investment strategies.
Bernd, how is your portfolio co
Press
First four companies selected to participate in the German Accelerator Life Sciences program in Cambridge
During the 34th JP Morgan Healthcare Conference, the German Accelerator Life Sciences (GALS) announced the first four companies to participate in its Cambridge-based program. AYOXXA Biosystems, PEPperPRINT, Personal MedSystems, and Sonormed will receive support tailored towards the specific needs of each company for up to 12 months. The scope of these young German companies ranges from treating tinnitus patients with filtered music and preventing stroke via a mobile ECG app to novel platform tec
Press
PEPperPRINT wins 30th German Industry’s Innovation Award
PEPperPRINT has won German Industry’s Innovation Award 2010 in the startup category. The biotech company from Heidelberg, Germany, was awarded in line of 30th German Industry’s Gala at the Congress Center Frankfurt by Federal Minister of Education and Research, Dr. Annette Schavan.
PEPperPRINT was selected out of more than 320 companies from all industry sectors by a committee composed of renowned leaders of German economy and sciences. Financed by High-Tech Gründerfonds, the startup com
Press
High-Tech Gründerfonds invests in PEPperPRINT’s new biochip platform
PEPperPRINT, a spin-off of the German Cancer Research Centre in Heidelberg, is financed by High-Tech Gründerfonds with a start-up investment of 500,000 Euro. Based on an award-winning and proprietary high resolution laser printing process, PEPperPRINT provides customized peptide microarrays in a truly cost-effective manner for the first time. Combined with speed and flexibility, the resulting molecular diversity is unrivalled: For the first time, proteome research is provided with a highly effi
Info & Contact
Address
Rischerstraße 12
69123 Heidelberg
69123 Heidelberg
In portfolio
26. Feb 2010